Cargando…

Questionnaire survey on lifestyle of patients with nonalcoholic steatohepatitis

Lack of exercise and excessive food intake are known to be the important causes of nonalcoholic steatohepatitis (NASH). To elucidate the relationship between lifestyle and NASH, we surveyed exercise and dietary habits, comparing them among 171 biopsy-proven NASH patients, 29 nonalcoholic fatty liver...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noto, Haruka, Tokushige, Katsutoshi, Hashimoto, Etsuko, Taniai, Makiko, Shiratori, Keiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	the Society for Free Radical Research Japan 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227825/ https://www.ncbi.nlm.nih.gov/pubmed/25411525 http://dx.doi.org/10.3164/jcbn.14-26

Ejemplares similares

The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus
por: Ikarashi, Yuichi, et al.
Publicado: (2017)

Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease
por: Tokushige, Katsutoshi, et al.
Publicado: (2013)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Bardet-Biedl Syndrome Caused by Skipping of SCLT1 Complicated by Microvesicular Steatohepatitis
por: Horiuchi, Kentaro, et al.
Publicado: (2020)

The Outcome of Cirrhotic Patients with Ascites Is Improved by the Normalization of the Serum Sodium Level by Tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2017)

The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease
por: Chishima, Sayaka, et al.
Publicado: (2017)

Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis
por: Sumida, Yoshio, et al.
Publicado: (2020)

Risk factors for recurrence of primary biliary cholangitis after liver transplantation in female patients: A Japanese multicenter retrospective study
por: Kogiso, Tomomi, et al.
Publicado: (2017)

Outcomes of fatty liver disease with and without metabolic comorbidities and risk factors for mortality
por: Ogasawara, Yuri, et al.
Publicado: (2023)

Impact of continued administration of tolvaptan on cirrhotic patients with ascites
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Risk factors for fatty pancreas and effects of fatty infiltration on pancreatic cancer
por: Otsuka, Nao, et al.
Publicado: (2023)

Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis
por: Akiyama, Kentaro, et al.
Publicado: (2017)

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
por: Tokushige, Katsutoshi, et al.
Publicado: (2021)

Long‐term outcome of Wilson's disease complicated by liver disease
por: Arai, Satoko, et al.
Publicado: (2021)

Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2023)

Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus
por: Kogiso, Tomomi, et al.
Publicado: (2018)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Brazilian survey
por: Cotrim, Helma P., et al.
Publicado: (2016)

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey
por: Alves, Venancio Avancini Ferreira, et al.
Publicado: (2016)

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2021)

Insulinoma in Patient With Nonalcoholic Steatohepatitis
por: Cain, Daniel, et al.
Publicado: (2023)

Risk factors for Fontan-associated hepatocellular carcinoma
por: Kogiso, Tomomi, et al.
Publicado: (2022)

Practical Use of Transient Elastography in Screening for Nonalcoholic Steatohepatitis in a Japanese Population
por: Hirono, Haruka, et al.
Publicado: (2019)

Necroptosis in Nonalcoholic Steatohepatitis
por: Gautheron, Jérémie, et al.
Publicado: (2015)

Long-term Follow-up of a Patient with Portal Hypertension and Hepatic Failure Due to Hepatic Hydatid Disease
por: Takenaka, Yuki, et al.
Publicado: (2021)

Successful Treatment of Ascites using a Denver(Ⓡ) Peritoneovenous Shunt in a Patient with Paroxysmal Nocturnal Hemoglobinuria and Budd-Chiari syndrome
por: Kogiso, Tomomi, et al.
Publicado: (2016)

The effect of β-caryophyllene on nonalcoholic steatohepatitis
por: Arizuka, Naoya, et al.
Publicado: (2017)

Human Nonalcoholic Steatohepatitis on a Chip
por: Freag, May S., et al.
Publicado: (2020)

Antioxidant Therapy in Nonalcoholic Steatohepatitis
por: Al-Busafi, Said A., et al.
Publicado: (2012)

The Immune Landscape in Nonalcoholic Steatohepatitis
por: Narayanan, Sowmya, et al.
Publicado: (2016)

High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis
por: Kawanaka, Miwa, et al.
Publicado: (2019)

Apoptosis and diagnosis of nonalcoholic steatohepatitis
por: Kim, Chang Wook, et al.
Publicado: (2011)

Betel Chewing and Nonalcoholic Steatohepatitis
por: Bleibel, Wissam, et al.
Publicado: (2018)

The metabolic basis of nonalcoholic steatohepatitis
por: Chakravarthy, Manu V., et al.
Publicado: (2020)

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview
por: Parthasarathy, Gopanandan, et al.
Publicado: (2020)

Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022)

Atypical Sarcoidosis Diagnosed by Massive Splenomegaly
por: Saito, Satomi, et al.
Publicado: (2019)

Giant Hepatic Hemangioma Causing Prolonged Fever and Indicated for Resection
por: Yoshimizu, Chihiro, et al.
Publicado: (2021)

Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis
por: Chen, Hui, et al.
Publicado: (2022)

Gut microbiota profile in patients with nonalcoholic fatty liver disease and presumed nonalcoholic steatohepatitis
por: Mohammadi, Zahra, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t0pq841lr3n48f6tqtmdl71lb1